chr15-43197334-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001114134.2(EPB42):c.2044G>A(p.Val682Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000179 in 1,614,174 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001114134.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPB42 | NM_001114134.2 | c.2044G>A | p.Val682Ile | missense_variant | 13/13 | ENST00000441366.7 | NP_001107606.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPB42 | ENST00000441366.7 | c.2044G>A | p.Val682Ile | missense_variant | 13/13 | 1 | NM_001114134.2 | ENSP00000396616 | P1 | |
EPB42 | ENST00000567019.2 | n.1550G>A | non_coding_transcript_exon_variant | 8/8 | 1 | |||||
EPB42 | ENST00000648595.1 | c.2134G>A | p.Val712Ile | missense_variant | 13/13 | ENSP00000497777 | ||||
EPB42 | ENST00000540029.5 | c.1810G>A | p.Val604Ile | missense_variant | 12/12 | 2 | ENSP00000444699 |
Frequencies
GnomAD3 genomes AF: 0.000677 AC: 103AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251488Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135918
GnomAD4 exome AF: 0.000127 AC: 186AN: 1461888Hom.: 1 Cov.: 30 AF XY: 0.000111 AC XY: 81AN XY: 727246
GnomAD4 genome AF: 0.000676 AC: 103AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74444
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 01, 2023 | BP4_strong - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
EPB42-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 08, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary spherocytosis type 5 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 24, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at